Nuclear Regulation m6A methylation of super-enhancer RNAs facilitates chromatin … – Nature.com Carmen Lillard Nov 17, 2023 m6A methylation of super-enhancer RNAs facilitates chromatin ... Nature.com
Nuclear Regulation m6A epitranscriptomic regulation of tissue homeostasis during … – Nature.com Carmen Lillard Apr 9, 2023 m6A epitranscriptomic regulation of tissue homeostasis during ... Nature.com
Nuclear Regulation Conserved reduction of m6A RNA modifications during aging and … – pnas.org Carmen Lillard Feb 22, 2023 Conserved reduction of m6A RNA modifications during aging and ... pnas.org
Nuclear Regulation RNA m6A regulates transcription via DNA demethylation and chromatin accessibility – Nature.com Carmen Lillard Sep 7, 2022 RNA m6A regulates transcription via DNA demethylation and chromatin accessibility Nature.com
Nuclear Regulation N6-methyladenosine (m6A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation… Carmen Lillard Aug 23, 2022 N6-methyladenosine (m6A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation Nature.com
Nuclear Regulation N6-methyladenosine (m6A) depletion regulates the exit from pluripotency by activating signaling… Carmen Lillard Dec 18, 2021 A deficiency in N6-methyladenosine (m6A) regulates the exit from pluripotency by activating signaling pathways in embryonic stem cells pnas.org
Nuclear Regulation Epigenetic regulatory role of m6A | PGPM – Dove Medical Press Carmen Lillard Oct 27, 2021 Epigenetic regulatory role of m6A | PGPM Dove Medical Press
Nuclear Regulation Regulation of Telomere Homeostasis and Genomic Stability in Cancer by N6 Adenosine Methylation (m6A)… Carmen Lillard Jul 28, 2021 Regulation of telomere homeostasis and genomic stability in cancer by N6 adenosine methylation (m6A) Scientific advances
Nuclear Regulation The m6A reader IMP2 directs autoimmune inflammation via an IL-17 and TNFα-dependent C / EBP… Carmen Lillard Jul 4, 2021 The m6A reader IMP2 directs autoimmune inflammation via an IL-17 and TNFα-dependent C / EBP transcription factor axis Science
Nuclear Regulation Mapping of m6A and its regulatory targets in prostate cancer shows low METTL3 induction of therapy… Carmen Lillard Jun 6, 2021 Mapping of m6A and its regulatory targets in prostate cancer shows a low METTL3 induction of therapy resistance DocWire News